{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:58Z","timestamp":1792784518318,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Genetics and Genomic Sciences"},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["U54 DK0839"],"award-info":[{"award-number":["U54 DK0839"]}]},{"name":"NCATS Rare Diseases Clinical Research Network"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of Rare Diseases Research"},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2018.11.012","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T01:16:44Z","timestamp":1543540604000},"page":"320-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Recent advances on porphyria genetics: Inheritance, penetrance &amp; molecular heterogeneity, including new modifying\/causative genes"],"prefix":"10.1016","volume":"128","author":[{"given":"Makiko","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenden","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.11.012_bb0005","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0010","series-title":"The Metabolib and Molecular Bases of Inherited Disease","first-page":"2961","article-title":"Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias","author":"Anderson","year":"2001"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0015","doi-asserted-by":"crossref","first-page":"E4071","DOI":"10.1073\/pnas.1719267115","article-title":"Human hydroxymethylbilane synthase: molecular dynamics of the pyrrole chain elongation identifies step-specific residues that cause AIP","volume":"115","author":"Bung","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.str.2018.02.012","article-title":"Structure of the mitochondrial aminolevulinic acid synthase, a key heme biosynthetic enzyme","volume":"26","author":"Brown","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0025","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/emboj\/17.9.2463","article-title":"Crystal structure of human uroporphyrinogen decarboxylase","volume":"17","author":"Whitby","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1107\/S2059798316019525","article-title":"Structural studies of substrate and product complexes of 5-aminolaevulinic acid dehydratase from humans, Escherichia coli and the hyperthermophile Pyrobaculum calidifontis","volume":"73","author":"Mills-Davies","year":"2017","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0035","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1093\/emboj\/20.21.5832","article-title":"Crystal structure of human uroporphyrinogen III synthase","volume":"20","author":"Mathews","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0040","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1093\/emboj\/cdg598","article-title":"Crystal structure of coproporphyrinogen III oxidase reveals cofactor geometry of Radical SAM enzymes","volume":"22","author":"Layer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0045","doi-asserted-by":"crossref","first-page":"38625","DOI":"10.1074\/jbc.M606640200","article-title":"Crystal structure of protoporphyrinogen oxidase from Myxococcus xanthus and its complex with the inhibitor acifluorfen","volume":"281","author":"Corradi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0050","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0969-2126(97)00299-2","article-title":"Crystal structure of ferrochelatase: the terminal enzyme in heme biosynthesis","volume":"5","author":"Al-Karadaghi","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0055","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.1016\/S0021-9258(19)81383-2","article-title":"Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme a synthase","volume":"263","author":"Smith","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3324\/haematol.2013.091991","article-title":"Heme and erythropoieis: more than a structural role","volume":"99","author":"Chiabrando","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0070","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0075","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/bmc.2994","article-title":"Liquid chromatography-tandem mass spectrometry of porphyrins and porphyrinogens in biological materials: separation and identification of interfering poly(ethylene) glycol by travelling wave ion mobility spectrometry\/tandem mass spectrometry","volume":"27","author":"Benton","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/bmc.860","article-title":"Porphomethene inhibitor of uroporphyrinogen decarboxylase: analysis by high-performance liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"21","author":"Danton","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/humu.23067","article-title":"Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease","volume":"37","author":"Chen","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0090","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddy030","article-title":"From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria","volume":"27","author":"Lenglet","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0095","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.61.11.1764","article-title":"Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias","volume":"61","author":"Solis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF01799566","article-title":"A retrospective study of a patient with homozygous form of acute intermittent porphyria","volume":"13","author":"Beukeveld","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00207051","article-title":"Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene","volume":"89","author":"Llewellyn","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01799567","article-title":"Identification of the mutations in the parents of a patient with a putative compound heterozygosity for acute intermittent porphyria","volume":"13","author":"Picat","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/000456329903600522","article-title":"Compound heterozygous hereditary coproporphyria with fluorescing teeth","volume":"36","author":"Doss","year":"1999","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(77)90386-5","article-title":"Homozygous case of hereditary coproporphyria","volume":"2","author":"Grandchamp","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10545-010-9237-9","article-title":"Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327R","volume":"34","author":"Hasanoglu","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1523-1747.1998.00148.x","article-title":"Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband","volume":"110","author":"Frank","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/pgmj.69.816.781","article-title":"Homozygous variegate porphyria: an evolving clinical syndrome","volume":"69","author":"Hift","year":"1993","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0140","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1523-1747.2001.01293.x","article-title":"Homozygous variegate porphyria: 20 y follow-up and characterization of molecular defect","volume":"116","author":"Kauppinen","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00278187","article-title":"The CpG dinucleotide and human genetic disease","volume":"78","author":"Cooper","year":"1988","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1034\/j.1399-0004.2002.620406.x","article-title":"Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene","volume":"62","author":"Floderus","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1469-1809.1998.6230225.x","article-title":"C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria","volume":"62","author":"Frank","year":"1998","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0165","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of north American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0170","first-page":"292","article-title":"Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele","volume":"58","author":"Gouya","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00439-003-1059-5","article-title":"Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias","volume":"114","author":"Gouya","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0180","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1172\/JCI117543","volume":"94","author":"Chen","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2362.1989.tb00252.x","article-title":"Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase","volume":"19","author":"Grandchamp","year":"1989","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcmd.2012.06.002","article-title":"Seven novel genetic mutations within the 5\u2032UTR and the housekeeping promoter of HMBS gene responsible for the non-erythroid form of acute intermittent porphyria","volume":"49","author":"Brancaleoni","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI10642","article-title":"Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria","volume":"107","author":"Solis","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2016.08.002","article-title":"The assessment of noncoding variant of PPOX gene in variegate porphyria reveals post-transcriptional role of the 5\u2032 untranslated exon 1","volume":"61","author":"Fiorentino","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbrc.2004.06.178","article-title":"Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria","volume":"321","author":"Onaga","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0210","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0215","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/515455","article-title":"Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria","volume":"60","author":"Puy","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0220","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s004390000323","article-title":"Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms","volume":"107","author":"Robreau-Fraolini","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cge.12562","article-title":"X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria","volume":"89","author":"Brancaleoni","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0230","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12452","article-title":"Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis","volume":"94","author":"Di Pierro","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0235","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0240","doi-asserted-by":"crossref","first-page":"E8045","DOI":"10.1073\/pnas.1700632114","article-title":"Mutation in human CLPX elevates levels of delta-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria","volume":"114","author":"Yien","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0245","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2011-03-342873","article-title":"ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria","volume":"118","author":"To-Figueras","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0250","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1471-4159.2007.04905.x","article-title":"Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity","volume":"103","author":"Hu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0255","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","article-title":"A variant of peptide transporter 2 predicts the severity of porphyria-associated kidney disease","volume":"28","author":"Tchernitchko","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0260","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1182\/blood.V97.10.2972","article-title":"Highly heterogeneous nature of delta-aminolevulinate dehydratase (ALAD) deficiencies in ALAD porphyria","volume":"97","author":"Maruno","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1155\/2003\/384971","article-title":"Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): extreme haplotype heterogeneity for the mutation R116W","volume":"19","author":"Tjensvoll","year":"2003","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0270","first-page":"64","article-title":"Evidence for an ancestral founder of the common R116W mutation in the hydroxymethylbilane synthase gene in acute intermittent porphyria in the Netherlands","volume":"55","author":"de Rooij","year":"2009","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000067665","article-title":"Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients","volume":"54","author":"Schneider-Yin","year":"2002","journal-title":"Hum. Hered."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0280","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1096-8628(19991008)86:4<366::AID-AJMG11>3.0.CO;2-#","article-title":"Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation","volume":"86","author":"De Siervi","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0285","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1529-8817.2003.00114.x","article-title":"Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria","volume":"68","author":"Guillen-Navarro","year":"2004","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ng0596-95","article-title":"A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria","volume":"13","author":"Meissner","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199201000-00001","article-title":"Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases","volume":"71","author":"Kauppinen","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0300","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4045\/tidsskr.13.0649","article-title":"Porphyrias in Norway","volume":"134","author":"Mykletun","year":"2014","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0305","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0310","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1093\/hmg\/ddi342","article-title":"Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria","volume":"14","author":"Schmitt","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/B:BOLI.0000016613.75677.05","article-title":"Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors","volume":"27","author":"Hessels","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0320","first-page":"861","article-title":"Residual activity of human porphobilinogen deaminase with R167Q or R167W mutations: an explanation for survival of homozygous and compound heterozygous acute intermittent porphyrics","volume":"48","author":"Edixhoven-Bosdijk","year":"2002","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0325","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/hmg\/7.12.1921","article-title":"Molecular characterization of homozygous variegate porphyria","volume":"7","author":"Roberts","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0330","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1086\/320118","article-title":"Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria","volume":"68","author":"Lamoril","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0335","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI111039","article-title":"Harderoporphyria: a variant hereditary coproporphyria","volume":"72","author":"Nordmann","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0340","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1073\/pnas.0506557102","article-title":"Structural basis of hereditary coproporphyria","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0345","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0350","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1172\/JCI108560","article-title":"An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity","volume":"58","author":"Kushner","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2141.2005.05852.x","article-title":"Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient","volume":"132","author":"Akagi","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0360","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1600-0625.2006.00464.x","article-title":"Dual porphyrias revisited","volume":"15","author":"Poblete-Gutierrez","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0365","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/jid.2011.186","article-title":"Digenic inheritance of mutations in the coproporphyrinogen oxidase and protoporphyrinogen oxidase genes in a unique type of porphyria","volume":"131","author":"van Tuyll Serooskerken","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0370","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2002.03557.x","article-title":"Congenital erythropoietic porphyria: advances in pathogenesis and treatment","volume":"117","author":"Desnick","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0375","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/jid.2011.5","article-title":"Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria","volume":"131","author":"Sarkany","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0380","first-page":"486","article-title":"Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report","volume":"179","author":"Podlipnik","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0385","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/sj.jid.5700924","article-title":"Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria","volume":"127","author":"Whatley","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0390","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/jid.2008.272","article-title":"Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance","volume":"129","author":"Holme","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0395","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.cell.2015.04.017","article-title":"Mitochondrial ClpX activates a key enzyme for heme biosynthesis and erythropoiesis","volume":"161","author":"Kardon","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0400","doi-asserted-by":"crossref","first-page":"20516","DOI":"10.1074\/jbc.M116.719161","article-title":"Novel mechanisms for heme-dependent degradation of ALAS1 protein as a component of negative feedback regulation of heme biosynthesis","volume":"291","author":"Kubota","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0405","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1046\/j.0022-202x.2001.01560.x","article-title":"Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells","volume":"117","author":"Aplin","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0410","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2004-12-4939","article-title":"Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells","volume":"107","author":"Goodwin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.11.012_bb0415","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0190-9622(92)70182-F","article-title":"Photosensitivity, abnormal porphyrin profile, and sideroblastic anemia","volume":"27","author":"Lim","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2018.11.012_bb0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2119\/molmed.2013.00003","article-title":"Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria","volume":"19","author":"Bishop","year":"2013","journal-title":"Mol. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218306450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218306450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:09Z","timestamp":1761089109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218306450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719218306450"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.11.012","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying\/causative genes","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}